Author

M. Favier

Observed names: Favier, Mathieu, M Favier, Mathieu Favier

Institution: Modélisation et Ingénierie des Systèmes Complexes Biologiques pour le Diagnostic

Observed institutions: Western University, Montreal Neurological Institute and Hospital, Centre National de la Recherche Scientifique, University of Ottawa, Inserm, Université Joseph Fourier, Douglas Mental Health University Institute, Grenoble Institute of Neurosciences, Modélisation et Ingénierie des Systèmes Complexes Biologiques pour le Diagnostic, Robarts Research Institute, McGill University, Concordia University, Université Grenoble Alpes

ORCID: 0000-0002-1680-3751

Observed ORCID: 0000-0002-1680-3751

OpenAlex ID: A5034602715

Implication of dopamine D3 receptor activation in the reversion of Parkinson’s disease-related motivational deficits

2014 · S Carnicella, G Drui, et al. · Translational Psychiatry · 82

PDF

Cholinergic dysfunction in the dorsal striatum promotes habit formation and maladaptive eating

2020 · Mathieu Favier, Helena Janickova, et al. · Journal of Clinical Investigation · 66

PDF

Pramipexole reverses Parkinson's disease‐related motivational deficits in rats

2014 · Mathieu Favier, Theo Duran, et al. · Movement Disorders · 65

Subthalamic deep brain stimulation differently alters striatal dopaminergic receptor levels in rats

2015 · Carole Carcenac, Mathieu Favier, et al. · Movement Disorders · 38

Implication of dorsostriatal D3 receptors in motivational processes: a potential target for neuropsychiatric symptoms in Parkinson’s disease

2017 · Mathieu Favier, Carole Carcenac, et al. · Scientific Reports · 25

PDF

Leveraging VGLUT3 Functions to Untangle Brain Dysfunctions

2021 · Mathieu Favier, Nicolas Pietrancosta, et al. · Trends in Pharmacological Sciences · 22

PDF

High-frequency stimulation of the subthalamic nucleus modifies the expression of vesicular glutamate transporters in basal ganglia in a rat model of Parkinson’s disease

2013 · Mathieu Favier, Carole Carcenac, et al. · BMC Neuroscience · 22

PDF

Metabotropic glutamate type 5 receptor binding availability during dextroamphetamine sensitization in mice and humans

2021 · Kelly Smart, Atsuko Nagano-Saito, et al. · Journal of Psychiatry and Neuroscience · 9

PDF

The human VGLUT3-pT8I mutation elicits uneven striatal DA signaling, food or drug maladaptive consumption in male mice

2024 · Mathieu Favier, Elena Martin Garcia, et al. · Nature Communications · 8

PDF

Dopamine D3 Receptors: A Potential Target to Treat Motivational Deficits in Parkinson’s Disease

2022 · Mathieu Favier, Carole Carcenac, et al. · Current topics in behavioral neurosciences · 8

RNA Editing Signatures Powered by Artificial Intelligence: A New Frontier in Differentiating Schizophrenia, Bipolar, and Schizoaffective Disorders

2024 · Francisco J. Checa-Robles, Nicolas Salvetat, et al. · International Journal of Molecular Sciences · 4

PDF

Motivation et apathie parkinsonienne

2017 · Mathieu Favier, Carole Carcenac, et al. · médecine/sciences · 4

PDF

Troubles des conduites alimentaires

2021 · Salah El Mestikawy, Mathieu Favier · médecine/sciences · 3

PDF

461. RNA Editing Signatures Powered by Artificial Intelligence: A New Frontier in Differentiating Schizophrenia, Bipolar and Schizoaffective Disorders

2025 · Dinah Weissmann, Francisco Checa Robles, et al. · Biological Psychiatry

New Acetylcholinesterase Inhibitors And Uses Thereof For Preventing And Treating Compulsive Disorders And Neurodegenerative Disorders

2024 · Pietrancosta, Nicolas, El Mestikawy, Salah, et al. · HAL

A rare variant of VGLUT3 (p.T8I) identified in patients with psychiatric disorders induces excessive habits, cocaine addiction-like and maladaptive eating in a mouse model

2022 · Favier, Mathieu, Martín-García, Elena, et al. · HAL

Works count: 16

Citation count: 356

H-index: 8

I10-index: 7